Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 8,150 | N/A | N/A |
| Marketable Securities | 50,760 | N/A | N/A |
| TOTAL | $60,205 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 445 | N/A | N/A |
| Other Non-Current Assets | 1,525 | 0 | 0 |
| TOTAL | $1,970 | $N/A | $N/A |
| Total Assets | $62,175 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,300 | 0 | 0 |
| Accrued Expenses | 3,890 | N/A | N/A |
| Other current liabilities | 91 | N/A | N/A |
| TOTAL | $5,935 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 16,873 | N/A | N/A |
| Deferred Revenues | 54 | N/A | N/A |
| Other Non-Current Liabilities | 131,589 | 0 | 0 |
| TOTAL | $148,570 | $N/A | $N/A |
| Total Liabilities | $154,505 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 2 | N/A | N/A |
| Retained earnings | -94,512 | N/A | N/A |
| Other shareholders' equity | -58 | 0 | 0 |
| TOTAL | $-92,330 | $N/A | $N/A |
| Total Liabilities And Equity | $62,175 | $0 | $0 |